Lispro insulin-induced lipoatrophy: a new case

  1. Sultan Al-Khenaizan1,*,
  2. Mastour Al Thubaiti1,
  3. Ibrahim Al Alwan2

Article first published online: 21 NOV 2007

DOI: 10.1111/j.1399-5448.2007.00296.x

Issue

Pediatric Diabetes

Pediatric Diabetes

Volume 8, Issue 6, pages 393–396, December 2007

Additional Information

How to Cite

Al-Khenaizan, S., Al Thubaiti, M. and Al Alwan, I. (2007), Lispro insulin-induced lipoatrophy: a new case. Pediatric Diabetes, 8: 393–396. doi: 10.1111/j.1399-5448.2007.00296.x

Author Information

  1. 1

    Division of Dermatology, Department of Medicine, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia

  2. 2

    Department of Pediatrics, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia

*Sultan Al-Khenaizan, MBBS, FRCPC, DABD Division of Dermatology Department of Medicine King Fahad National Guard Hospital P.O. Box 22490 Riyadh 11426 Kingdom of Saudi Arabia. Tel: (966-1) 252-0088x4175; fax: (966-1) 252-0088x4229; e-mail: khenaizans@ngha.med.sa

Publication History

  1. Issue published online: 21 NOV 2007
  2. Article first published online: 21 NOV 2007
  3. Submitted 15 February 2006. Accepted for publication 21 July 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (83K)

Keywords:

  • diabetes;
  • insulin;
  • lipoatrophy;
  • lipodystrophy

Abstract:  Lipoatrophy (LA) is a rare complication of insulin treatment in type 1 diabetes mellitus. The pathogenesis of insulin-induced LA is still unknown. Many theories suggest immunological reactions. We report a 4-yr-old Saudi girl with LA probably induced by lispro insulin. A review of the literature on the clinical features, pathophysiology, differential diagnosis, and treatment is briefly discussed.

View Full Article (HTML) Get PDF (83K)